Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

Miguel Gonzalez-Velez, MD

Articles by Miguel Gonzalez-Velez, MD

sebra - stock.adobe.com

How to approach immune checkpoint inhibitor therapy in prostate cancer

ByMiguel Gonzalez-Velez, MD,Alan H. Bryce, MD

August 18th 2020

Next-generation sequencing identifies subtypes that may benefit from immune checkpoint inhibitors.

Latest Updated Articles

Trending on Urology Times

FDA approves enfortumab vedotin plus pembrolizumab for MIBC

Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy

Urocross shows sustained benefit through 24 months post-removal

Study suggests tamsulosin deprescribing may be appropriate for select men with BPH

Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC